Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn A Maier

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cold Spring Harbor Protocols|June 3, 2010
Production of SV40-derived vectorsDavid S Strayer, Christine Mitchell, Dawn A Maier, et al.
Cold Spring Harbor Protocols|June 3, 2010
Titering replication-defective rSV40 vectorsDavid S Strayer, Christine Mitchell, Dawn A Maier, et al.
Journal of Translational Medicine|November 16, 2011
Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysateCheryl L-L Chiang, Dawn A Maier, Lana E Kandalaft, et al.
Human Gene Therapy|January 31, 2013
Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5Dawn A Maier, Andrea L Brennan, Shuguang Jiang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cold Spring Harbor Protocols|June 3, 2010
Production of SV40-derived vectorsDavid S Strayer, Christine Mitchell, Dawn A Maier, et al.
Cold Spring Harbor Protocols|June 3, 2010
Titering replication-defective rSV40 vectorsDavid S Strayer, Christine Mitchell, Dawn A Maier, et al.
Journal of Translational Medicine|November 16, 2011
Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysateCheryl L-L Chiang, Dawn A Maier, Lana E Kandalaft, et al.
Human Gene Therapy|January 31, 2013
Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5Dawn A Maier, Andrea L Brennan, Shuguang Jiang, et al.
Pageof 1